Secondary damage is a critical determinant of the functional outcome in patients with spinal cord injury (SCI), and involves multiple mechanisms of which the most important is the loss of nerve cells mediated by multiple factors. Autophagy can result in cell death, and plays a key role in the development of SCI. It has been recognized that valproic acid (VPA) is neuroprotective in certain experimental animal models, however, the levels of autophagic changes in the process of neuroprotection by VPA treatment following SCI are still unknown. In the present study, we determined the extent of autophagy after VPA treatment in a rat model of SCI. We found that both the mRNA and protein levels of Beclin-1 and LC3 were significantly increased at 1, 2, and 6 h after SCI and peaked at 2 h; however, Western blot showed that autophagy was markedly decreased by VPA treatment at 2 h post-injury. Besides, post-SCI treatment with VPA improved the Basso-Beattie-Bresnahan scale, increased the number of ventral horn motoneurons, and reduced myelin sheath damage compared with vehicle-treated animals at 42 days after SCI. Together, our results demonstrated the characteristics of autophagy expression following SCI, and found that VPA reduced autophagy and enhanced motor function.
INtrODUctION
Currently, trauma is the leading cause of mortality in the young population [1] . Trauma-induced spinal cord injury (SCI) drastically impinges on the quality of life in survivors who have residual disability, and causes a healthcare burden nationally [2, 3] . In China, the incidence of SCI caused by car crashes, construction and mining accidents has increased ten-fold in the past decade [4] . Injury to the spinal cord causes primary and secondary damage. The secondary damage is often more important in determining the functional outcome and provides a practical target for therapeutic intervention. Although the secondary injury can be regulated, the mechanism is complex [4] , and clinical treatment for SCI, especially for recovery of motor function, is not satisfactory [5] . Therefore, it is urgent to further understand the mechanisms underlying the development of SCI and to seek better and more efficient treatments to improve the quality of life of patients.
The post-traumatic systemic stress response is Hai-Hu Hao, et al. VPA reduces autophagy and promotes functional recovery after SCI in rats 485 implicated in the functional loss after SCI [5, 6] . The integrated stress response [7] plays a pivotal role in maintaining homeostasis in the body. Autophagy, a central component of this response [7] , is influential in the development and progression of damage after injury [8] [9] [10] . Autophagy is an intracellular degradation system that delivers proteins and organelles to lysosomes for degradation [11] . It is involved in the development of many diseases [12, 13] , but both excessive and deficient autophagy are linked to pathophysiological events [14] . Recent studies confirmed that autophagy promotes secondary cell death in traumatic SCI [10, 15, 16] and affects functional recovery [17] . Therefore, we hypothesized that secondary injury can be controlled and functional outcome can be improved by the interruption of autophagy to some extent after SCI.
In many animal models, histone deacetylase (HDAC)
inhibitors have neuroprotective effects in various neurological conditions [18] [19] [20] . Valproic acid (VPA) is an HDAC inhibitor, and plays a key role in fundamental cellular activities such as gene transcription [21] . A recent study in glioma cell lines demonstrated that VPA induces autophagy [22] .
Therefore, the level of autophagy in spinal cord tissue may be influenced and motor function may be improved by VPA after SCI.
In this study, we used a rat model of SCI to investigate the characteristics of autophagy after SCI as well as the effect of VPA treatment on autophagy. In addition, we assessed the neuroprotective effect of VPA in acute SCI. 
MAtErIALs AND MEtHODs

Animals
spinal cord contusion Injury
Animals were anesthetized with 10% chloral hydrate (0.3 mL/100 g, i.p.), and SCI was induced using a modified New York University impactor [18, 23, 24] . In brief, the T10 segment was exposed by laminectomy. Contusion injury was induced by dropping a 10-g rod (tip diameter, 2.5 mm) from a height of 25 mm onto the exposed cord. The shamoperated animals received only a laminectomy to expose the cord, but were not subjected to impact injury. Manual bladder expression was performed on each animal twice daily until the recovery of sphincter control.
VPA treatment
Rats randomly received VPA (300 mg/kg, i.p., twice daily)
or an equal volume of saline vehicle for two weeks, starting immediately after the injury, as reported previously [21, 25] . A group of sham-operated rats was included as an additional control.
Western blot
At different time points 
Histological Assessment
Nine sections collected at 42 days after injury were Nissl- [26] .
To evaluate the extent of spared myelin in white matter, the cross-sections were stained with Luxol fast blue (LFB) and examined 42 days after SCI. In brief, the sections were captured using an Olympus digital camera. The LFBpositive area (blue) of spared white matter was analyzed by ImageJ 1.44p [26] , and the ratio of LFB-stained residual white matter to normal white matter was calculated.
behavioral testing
The motor function of the hindlimbs was evaluated using the Basso-Beattie-Bresnahan (BBB) scale [27] for six weeks following SCI. The BBB locomotor rating scale is widely used to test the behavioral consequences of SCI in rats [28] . The BBB values were determined by three trained observers who were unaware of the experimental procedures, and averaged.
statistical Analysis
Data are expressed as mean ± SD, and were analyzed with one-way ANOVA with Bonferroni post hoc analysis. BBB scores were analyzed with repeated measures ANOVA followed by the Tukey-Kramer test. All statistical values were calculated using SPSS 16.0. P <0.05 was considered to be statistically significant.
rEsULts
Expression of Lc3 and beclin-1 Increased in scI rats
To investigate the changes in autophagy at different times after SCI, the mRNA expression and protein levels of Beclin-1 and LC3 were measured by real-time PCR and
Western blot analysis respectively. The level of autophagy increased (P <0.05) at 1, 2, and 6 h after injury compared with the sham-operated group. Both the protein and mRNA levels of LC3 and Beclin-1 peaked at 2 h post-surgery versus the sham group (P <0.01) (Figs. 1 and 2) .
VPA reduced the Levels of Lc3 and beclin-1
Western blot analysis showed that VPA treatment decreased the Beclin-1 and LC3-II protein levels at 2 h after SCI compared with the vehicle-treated rats (P <0.05, P <0.01; Fig. 3A-C) . Immunofluorescence staining of the epicenter sections also showed that at 2 h after the injury, LC3 was increased compared with the sham operation, and displayed a punctate pattern in the cell soma. VPA decreased the LC3 staining, as revealed by decreased numbers of LC3 puncta under confocal microscopy ( Fig.   3D ).
VPA Promoted Neuroprotection Following scI
At 42 days after injury, there was a trend of increase in the number of motoneurons near the injury epicenter in VPAtreated rats (relative to the vehicle control). VPA increased the number of motoneurons at 2 mm both rostral and caudal to the epicenter (P <0.05 vs vehicle control) (Fig.   4C ). Representative photomicrographs of motoneurons from VPA-treated and vehicle-treated rats are shown in Fig.   4A and B. VPA also reduced myelin sheath damage 1 mm rostral to the epicenter at 42 days after SCI (Fig. 5B) , as reflected by LFB staining compared with the vehicle control (Fig. 5A ).
The total area of tissue preserved in injured rats receiving VPA or vehicle was apparently smaller than that in the sham control (Fig. 5C) . VPA increased the LFB-positive spared myelin sheath ratio (30.96 ± 0.58% vs 19.67 ± 0.83% in vehicle control, P <0.05, Fig. 5D ) at 1 mm rostral to the epicenter at 42 days after SCI.
VPA Promoted Functional recovery Following scI
To assess the effect of VPA on hindlimb recovery from SCI, the BBB score was measured once a week for six weeks (Fig. 6) . From weeks 4 to 6 after injury, the scores in the VPA-treated animals were consistently higher than those in the vehicle-treated animals. At 42 days, the scores declined in the VPA-treated and vehicle-treated groups compared with the sham-operated group, but the VPA-treated animals had higher scores than the vehicle-treated animals (BBB scores: Sham, 21; VPA, 13.39 ± 0.85; Vehicle, 10.13 ± 0.81, P <0.05 for both comparisons; Fig. 6 ).
DIscUssION
In the present study, we demonstrated that the characteristics of autophagic expression in the thoracic spinal cord increased at 1, 2, and 6 h after SCI, and administration of VPA markedly decreased the Beclin-1 and LC3 protein levels at 2 h after SCI. As expected, VPA significantly reduced neuronal damage and improved locomotor function after SCI. To our knowledge, these are the first findings on a link between VPA-mediated neuroprotection and autophagy following SCI.
All forms of cell death (autophagy, apoptosis, and necrosis) can occur in neurons after cerebral ischemia [13] .
Although autophagy and apoptosis spread into the lesion penumbra later than the necrosis that occurs at the injury epicenter after SCI, they can promote secondary cell death [9, 15] .
Autophagy is a physiological phenomenon that plays an important role in maintaining cellular homeostasis.
Upon starvation or injury, autophagy is initiated to engulf damaged organelles and proteins to provide additional energy; however, in pathological conditions, autophagy may promote secondary cell death and become another form of cell death [9, 29] . Previous research has demonstrated that Beclin-1 and LC3, biological markers of autophagy, can be detected in spinal tissue after SCI [9, 16, 30] . Beclin-1 is a unique autophagy-related protein, thought to be important in mediating the localization of other autophagy proteins to pre-autophagosomal structures [31] . Therefore, it is commonly used for autophagy detection. LC3, a mammalian homolog of yeast Atg8, is the most important and reliable marker in autophagy research [32] . In the formation of the autophagy membrane, the conversion of LC3-I to LC3-II is considered to be one of the symbols of autophagic induction, so LC3-II is often used as a marker for autophagosomes [16] . A recent study found that the expression of Beclin-1 protein increases and autophagic cell death is promoted after SCI in a mouse model of spinal cord hemisection injury [9] .
Similar to previous studies [9, 30] , here the expression of Beclin-1 increased sharply after contusion injury. The level of LC3-II was raised at 1 h after SCI, peaked at 2 h, and then decreased. The time-course of LC3-II change in our study is consistent with the finding by Chen [16] , but not with another report showing that the rise of LC3-II is relatively late after SCI [15] . This discrepancy may reflect differences in the model.
To minimize the secondary cell death after SCI, it is imperative that drug therapy is performed promptly. VPA, [21, 33] . In the present study, we showed that autophagic activity was markedly inhibited by VPA, possibly by lowering the Beclin-1 and LC3-II protein levels. Immunofluorescence and laser confocal microscopy also demonstrated that the LC3 fluorescence that was located in the cytoplasm was markedly decreased at the epicenter in the VPA group. These data indicate that autophagic cell death is reduced by inhibiting autophagic activity by VPA.
Previous studies showed that VPA promotes the repair of sciatic nerve injury [18] , has anti-inflammatory and neuroprotective effects [25] and increases the expression of Bcl-2 and Hsp70 to inhibit apoptosis [21] . Combined with our results, these observations show that VPA has multiple roles in SCI. In the present study, VPA improved functional recovery after injury, significantly decreased the demyelinated area, and increased the number of spared motor neurons. Therefore, we suggest that VPA-induced neuroprotection and functional recovery following SCI may be, at least in part, associated with the inhibition of SCIinduced autophagy activation.
Further research is warranted to verify the specific role of autophagy in VPA-mediated neuroprotection after SCI. Besides, although Fu et al. [22] showed that the ERK pathway is involved in VPA-induced autophagy in glioma cells, the specific signaling pathways for VPA inhibition of autophagy after injury remain to be determined and need further studies. In conclusion, our results suggest that VPA inhibits injury-induced autophagy. Treatment using VPA for SCI may provide a new strategy to reduce secondary damage.
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